Agomelatine drives sex-specific neuroprotection and reduced pathology in rat and human Alzheimer's models
Grace Terry, Siaresh Aziz, Nishat Raihana, Lei Xie, Patricia Rockwell, Peter A. Serrano, Maria E. Figueiredo-Pereira
This paper identifies agomelatine as a disease-modifying candidate for Alzheimer's disease, showing sex-specific neuroprotection and reduced pathology in both rat and human models.
bioRxiv · Jan 21, 2026 · PreprintNeuroscience